Follow the people · Insider
Roger Jeffs
Roger Jeffs files insider transactions with the SEC as a chief executive officer of Liquidia (LQDA). We hold 27 disclosed purchases and sales filed since 6 January 2006, 3 of them in the last 90 days.
- Files forLQDA
- Disclosed buys and sells27 in all, 3 in the last 90 days
- Last disclosure14 July 2026
Positions held
9 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 18 November 2020 — 13 July 2026Chief Executive Officer · Liquidia (LQDA)89 Form 4 lines · source: SEC Form 4
- Filed 19 November 2015 — 11 June 2026Director · Axsome Therapeutics (AXSM)62 Form 4 lines · source: SEC Form 4
- Filed 27 September 2017 — 24 June 2021Director · Albireo Pharma (ALBO)6 Form 4 lines · source: SEC Form 4
- Filed 5 July 2017 — 12 November 2019Director · Dova Pharmaceuticals (DOVA)10 Form 4 lines · source: SEC Form 4
- Filed 15 April 2019 — 15 April 2019Director · Axovant Sciences (AXGT)1 Form 4 line · source: SEC Form 4
- Filed 27 June 2017 — 7 September 2018Director · Sangamo Therapeutics (SGMO)4 Form 4 lines · source: SEC Form 4
- Filed 13 February 2018 — 13 February 2018Director · Axovant Sciences (AXON)1 Form 4 line · source: SEC Form 4
- Filed 5 January 2005 — 15 March 2016President & Co-CEO · United Therapeutics (UTHR)984 Form 4 lines · source: SEC Form 4
- Filed 1 November 2007 — 1 November 2007President & COO · United Therapeutics (ut)5 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 13,834 shares of LiquidiaSEC Form 414 July 2026Common Stock · traded 10 July 2026 · filed 14 July 2026
- exercised options over 14,333 shares of LiquidiaSEC Form 414 July 2026Common Stock · traded 10 July 2026 · filed 14 July 2026
- ▼ sold on the open market 2,505 shares of LiquidiaSEC Form 414 July 2026Common Stock · traded 13 July 2026 · filed 14 July 2026
- ▼ sold on the open market 32,744 shares of LiquidiaSEC Form 414 July 2026Common Stock · traded 13 July 2026 · filed 14 July 2026
- exercised options over 13,834 shares of Liquidia (a derivative holding)SEC Form 414 July 2026Performance Stock Units · traded 10 July 2026 · filed 14 July 2026
- exercised options over 14,333 shares of Liquidia (a derivative holding)SEC Form 414 July 2026Performance Stock Units · traded 10 July 2026 · filed 14 July 2026
- ▼ sold on the open market 6,428 shares of LiquidiaSEC Form 428 May 2026Common Stock · traded 27 May 2026 · filed 28 May 2026
- ▼ sold on the open market 25,000 shares of LiquidiaSEC Form 426 May 2026Common Stock · traded 21 May 2026 · filed 26 May 2026
- ▼ sold on the open market 25,000 shares of LiquidiaSEC Form 426 May 2026Common Stock · traded 22 May 2026 · filed 26 May 2026
- ▼ sold on the open market 25,000 shares of LiquidiaSEC Form 426 May 2026Common Stock · traded 26 May 2026 · filed 26 May 2026
- ▼ sold on the open market 25,000 shares of LiquidiaSEC Form 420 May 2026Common Stock · traded 18 May 2026 · filed 20 May 2026
- ▼ sold on the open market 25,000 shares of LiquidiaSEC Form 420 May 2026Common Stock · traded 19 May 2026 · filed 20 May 2026
- ▼ sold on the open market 25,000 shares of LiquidiaSEC Form 420 May 2026Common Stock · traded 20 May 2026 · filed 20 May 2026
- ▼ sold on the open market 25,000 shares of LiquidiaSEC Form 415 May 2026Common Stock · traded 13 May 2026 · filed 15 May 2026
- ▼ sold on the open market 25,000 shares of LiquidiaSEC Form 415 May 2026Common Stock · traded 14 May 2026 · filed 15 May 2026
- ▼ sold on the open market 25,000 shares of LiquidiaSEC Form 415 May 2026Common Stock · traded 15 May 2026 · filed 15 May 2026
- ▼ sold on the open market 25,000 shares of LiquidiaSEC Form 412 May 2026Common Stock · traded 8 May 2026 · filed 12 May 2026
- ▼ sold on the open market 25,000 shares of LiquidiaSEC Form 412 May 2026Common Stock · traded 11 May 2026 · filed 12 May 2026
- ▼ sold on the open market 25,000 shares of LiquidiaSEC Form 412 May 2026Common Stock · traded 12 May 2026 · filed 12 May 2026
- ▼ sold on the open market 25,000 shares of LiquidiaSEC Form 47 May 2026Common Stock · traded 5 May 2026 · filed 7 May 2026
- ▼ sold on the open market 25,000 shares of LiquidiaSEC Form 47 May 2026Common Stock · traded 6 May 2026 · filed 7 May 2026
- ▼ sold on the open market 25,000 shares of LiquidiaSEC Form 47 May 2026Common Stock · traded 7 May 2026 · filed 7 May 2026
- ▼ sold on the open market 18,839 shares of LiquidiaSEC Form 421 April 2026Common Stock · traded 17 April 2026 · filed 21 April 2026
- ▼ sold on the open market 3,300 shares of LiquidiaSEC Form 416 April 2026Common Stock · traded 14 April 2026 · filed 16 April 2026
- ▼ sold on the open market 25,000 shares of LiquidiaSEC Form 416 April 2026Common Stock · traded 15 April 2026 · filed 16 April 2026
- ▼ sold on the open market 25,000 shares of LiquidiaSEC Form 416 April 2026Common Stock · traded 16 April 2026 · filed 16 April 2026
- exercised options over 13,834 shares of LiquidiaSEC Form 414 April 2026Common Stock · traded 10 April 2026 · filed 14 April 2026
- exercised options over 14,333 shares of LiquidiaSEC Form 414 April 2026Common Stock · traded 10 April 2026 · filed 14 April 2026
- ▼ sold on the open market 32,744 shares of LiquidiaSEC Form 414 April 2026Common Stock · traded 13 April 2026 · filed 14 April 2026
- ▼ sold on the open market 21,433 shares of LiquidiaSEC Form 414 April 2026Common Stock · traded 10 April 2026 · filed 14 April 2026
- exercised options over 13,834 shares of Liquidia (a derivative holding)SEC Form 414 April 2026Performance Stock Units · traded 10 April 2026 · filed 14 April 2026
- exercised options over 14,333 shares of Liquidia (a derivative holding)SEC Form 414 April 2026Performance Stock Units · traded 10 April 2026 · filed 14 April 2026
- ▼ sold on the open market 25,000 shares of LiquidiaSEC Form 413 April 2026Common Stock · traded 9 April 2026 · filed 13 April 2026
- was granted 115,344 shares of LiquidiaSEC Form 421 January 2026Common Stock · traded 16 January 2026 · filed 21 January 2026
- was granted 173,016 shares of Liquidia (a derivative holding)SEC Form 421 January 2026Performance Stock Units · traded 16 January 2026 · filed 21 January 2026
- was granted 173,016 shares of Liquidia (a derivative holding)SEC Form 421 January 2026Performance Stock Units · traded 16 January 2026 · filed 21 January 2026
- was granted 115,344 shares of LiquidiaSEC Form 421 January 2026Common Stock · traded 16 January 2026 · filed 21 January 2026
- exercised options over 13,833 shares of LiquidiaSEC Form 413 January 2026Common Stock · traded 9 January 2026 · filed 13 January 2026
- exercised options over 57,332 shares of LiquidiaSEC Form 413 January 2026Common Stock · traded 9 January 2026 · filed 13 January 2026
- ▼ sold on the open market 66,610 shares of LiquidiaSEC Form 413 January 2026Common Stock · traded 12 January 2026 · filed 13 January 2026
- exercised options over 13,833 shares of Liquidia (a derivative holding)SEC Form 413 January 2026Performance Stock Units · traded 9 January 2026 · filed 13 January 2026
- exercised options over 57,332 shares of Liquidia (a derivative holding)SEC Form 413 January 2026Performance Stock Units · traded 9 January 2026 · filed 13 January 2026
- exercised options over 13,833 shares of Liquidia (a derivative holding)SEC Form 413 January 2026Performance Stock Units · traded 9 January 2026 · filed 13 January 2026
- exercised options over 57,332 shares of Liquidia (a derivative holding)SEC Form 413 January 2026Performance Stock Units · traded 9 January 2026 · filed 13 January 2026
- exercised options over 13,833 shares of LiquidiaSEC Form 413 January 2026Common Stock · traded 9 January 2026 · filed 13 January 2026
- exercised options over 57,332 shares of LiquidiaSEC Form 413 January 2026Common Stock · traded 9 January 2026 · filed 13 January 2026
- ▼ sold on the open market 66,610 shares of LiquidiaSEC Form 413 January 2026Common Stock · traded 12 January 2026 · filed 13 January 2026
- exercised options over 13,834 shares of Liquidia (a derivative holding)SEC Form 415 October 2025Performance Stock Units · traded 10 October 2025 · filed 15 October 2025
- exercised options over 13,834 shares of LiquidiaSEC Form 415 October 2025Common Stock · traded 10 October 2025 · filed 15 October 2025
- ▼ sold on the open market 20,261 shares of LiquidiaSEC Form 415 October 2025Common Stock · traded 13 October 2025 · filed 15 October 2025
- exercised options over 13,833 shares of Liquidia (a derivative holding)SEC Form 415 July 2025Performance Stock Units · traded 11 July 2025 · filed 15 July 2025
- exercised options over 13,833 shares of LiquidiaSEC Form 415 July 2025Common Stock · traded 11 July 2025 · filed 15 July 2025
- ▼ sold on the open market 20,252 shares of LiquidiaSEC Form 415 July 2025Common Stock · traded 14 July 2025 · filed 15 July 2025
- exercised options over 13,833 shares of Liquidia (a derivative holding)SEC Form 415 July 2025Performance Stock Units · traded 11 July 2025 · filed 15 July 2025
- exercised options over 13,833 shares of LiquidiaSEC Form 415 July 2025Common Stock · traded 11 July 2025 · filed 15 July 2025
- ▼ sold on the open market 20,252 shares of LiquidiaSEC Form 415 July 2025Common Stock · traded 14 July 2025 · filed 15 July 2025
- was granted 3,166 shares of Axsome Therapeutics (a derivative holding)SEC Form 410 June 2025Stock Option (Right to Buy) · traded 6 June 2025 · filed 10 June 2025
- was granted 1,429 shares of Axsome Therapeutics (a derivative holding)SEC Form 410 June 2025Restricted Stock Units · traded 6 June 2025 · filed 10 June 2025
- exercised options over 69,169 shares of Liquidia (a derivative holding)SEC Form 45 June 2025Performance Stock Units · traded 3 June 2025 · filed 5 June 2025
- exercised options over 69,169 shares of LiquidiaSEC Form 45 June 2025Common Stock · traded 3 June 2025 · filed 5 June 2025
- ▼ sold on the open market 30,610 shares of LiquidiaSEC Form 45 June 2025Common Stock · traded 4 June 2025 · filed 5 June 2025
- ▼ sold on the open market 14,130 shares of LiquidiaSEC Form 416 April 2025Common Stock · traded 14 April 2025 · filed 16 April 2025
- was granted 1,408 shares of Axsome Therapeutics (a derivative holding)SEC Form 425 February 2025Stock Option (Right to Buy) · traded 21 February 2025 · filed 25 February 2025
- was granted 229,327 shares of Liquidia (a derivative holding)SEC Form 414 January 2025Performance Stock Units · traded 11 January 2025 · filed 14 January 2025
- was granted 229,327 shares of LiquidiaSEC Form 414 January 2025Common Stock · traded 11 January 2025 · filed 14 January 2025
- ▼ sold on the open market 22,343 shares of LiquidiaSEC Form 414 January 2025Common Stock · traded 14 January 2025 · filed 14 January 2025
- ▼ sold on the open market 8,053 shares of LiquidiaSEC Form 415 October 2024Common Stock · traded 14 October 2024 · filed 15 October 2024
- ▼ sold on the open market 8,053 shares of LiquidiaSEC Form 415 July 2024Common Stock · traded 12 July 2024 · filed 15 July 2024
- was granted 5,799 shares of Axsome Therapeutics (a derivative holding)SEC Form 411 June 2024Stock Option (Right to Buy) · traded 7 June 2024 · filed 11 June 2024
- ▼ sold on the open market 8,360 shares of LiquidiaSEC Form 416 April 2024Common Stock · traded 12 April 2024 · filed 16 April 2024
- ▼ sold on the open market 28,583 shares of LiquidiaSEC Form 419 March 2024Common Stock · traded 18 March 2024 · filed 19 March 2024
- exercised options over 13,000 shares of Axsome Therapeutics (a derivative holding)SEC Form 415 March 2024Stock Option (Right to Buy) · traded 14 March 2024 · filed 15 March 2024
- exercised options over 16,976 shares of Axsome Therapeutics (a derivative holding)SEC Form 415 March 2024Stock Option (Right to Buy) · traded 14 March 2024 · filed 15 March 2024
- exercised options over 2,347 shares of Axsome Therapeutics (a derivative holding)SEC Form 415 March 2024Stock Option (Right to Buy) · traded 15 March 2024 · filed 15 March 2024
- exercised options over 13,000 shares of Axsome TherapeuticsSEC Form 415 March 2024Common Stock · traded 14 March 2024 · filed 15 March 2024
- ▼ sold on the open market 13,000 shares of Axsome TherapeuticsSEC Form 415 March 2024Common Stock · traded 14 March 2024 · filed 15 March 2024
- exercised options over 16,976 shares of Axsome TherapeuticsSEC Form 415 March 2024Common Stock · traded 14 March 2024 · filed 15 March 2024
- ▼ sold on the open market 16,976 shares of Axsome TherapeuticsSEC Form 415 March 2024Common Stock · traded 14 March 2024 · filed 15 March 2024
- exercised options over 2,347 shares of Axsome TherapeuticsSEC Form 415 March 2024Common Stock · traded 15 March 2024 · filed 15 March 2024
- ▼ sold on the open market 2,347 shares of Axsome TherapeuticsSEC Form 415 March 2024Common Stock · traded 15 March 2024 · filed 15 March 2024
- was granted 1,425 shares of Axsome Therapeutics (a derivative holding)SEC Form 429 February 2024Stock Option (Right to Buy) · traded 27 February 2024 · filed 29 February 2024
- was granted 221,338 shares of Liquidia (a derivative holding)SEC Form 416 January 2024Performance Stock Units · traded 11 January 2024 · filed 16 January 2024
- was granted 221,338 shares of LiquidiaSEC Form 416 January 2024Common Stock · traded 11 January 2024 · filed 16 January 2024
- ▲ bought on the open market 139,665 shares of LiquidiaSEC Form 418 December 2023Common Stock · traded 14 December 2023 · filed 18 December 2023
- was granted 993 shares of LiquidiaSEC Form 410 April 2023Common Stock · traded 31 August 2022 · filed 10 April 2023
- was granted 371,154 shares of Liquidia (a derivative holding)SEC Form 413 January 2023Stock Option (Right to Buy) · traded 11 January 2023 · filed 13 January 2023
- was granted 289,500 shares of LiquidiaSEC Form 413 January 2023Common Stock · traded 11 January 2023 · filed 13 January 2023
- exercised options over 15,807 shares of Liquidia (a derivative holding)SEC Form 45 January 2023Restricted Stock Unit · traded 3 January 2023 · filed 5 January 2023
- exercised options over 15,807 shares of LiquidiaSEC Form 45 January 2023Common Stock · traded 3 January 2023 · filed 5 January 2023
- exercised options over 47,423 shares of Liquidia (a derivative holding)SEC Form 44 October 2022Restricted Stock Unit · traded 3 October 2022 · filed 4 October 2022
- exercised options over 47,423 shares of LiquidiaSEC Form 44 October 2022Common Stock · traded 3 October 2022 · filed 4 October 2022
- ▲ bought on the open market 43,820 shares of LiquidiaSEC Form 47 September 2022Common Stock · traded 6 September 2022 · filed 7 September 2022
- ▲ bought on the open market 993 shares of LiquidiaSEC Form 41 September 2022Common Stock · traded 31 August 2022 · filed 1 September 2022
- was granted 931,475 shares of Liquidia (a derivative holding)SEC Form 422 June 2022Non-Qualified Stock Option (right to buy) · traded 17 June 2022 · filed 22 June 2022
- ▲ bought on the open market 28,000 shares of LiquidiaSEC Form 425 May 2022Common Stock · traded 24 May 2022 · filed 25 May 2022
- was granted 154,167 shares of LiquidiaSEC Form 420 April 2022Common Stock · traded 31 March 2022 · filed 20 April 2022
- was granted 1,682,827 shares of Liquidia (a derivative holding)SEC Form 44 January 2022Non-Qualified Stock Option (right to buy) · traded 3 January 2022 · filed 4 January 2022
- was granted 63,230 shares of Liquidia (a derivative holding)SEC Form 44 January 2022Restricted Stock Unit · traded 3 January 2022 · filed 4 January 2022
- was granted 20,000 shares of Liquidia (a derivative holding)SEC Form 41 September 2021Non-Qualified Stock Option (right to buy) · traded 20 August 2021 · filed 1 September 2021
- ▲ bought on the open market 99,206 shares of LiquidiaSEC Form 415 April 2021Common Stock · traded 13 April 2021 · filed 15 April 2021
- was granted 30,353 shares of Liquidia (a derivative holding)SEC Form 426 March 2021Non-Qualified Stock Option (right to buy) · traded 24 March 2021 · filed 26 March 2021
- was granted 1,463 shares of Axsome Therapeutics (a derivative holding)SEC Form 49 March 2021Stock Option (Right to Buy) · traded 5 March 2021 · filed 9 March 2021
- was granted 30,000 shares of Liquidia (a derivative holding)SEC Form 419 November 2020Non-Qualified Stock Option (right to buy) · traded 18 November 2020 · filed 19 November 2020
- acquired or disposed of, other 1,387,500 shares of LiquidiaSEC Form 419 November 2020Common Stock · traded 18 November 2020 · filed 19 November 2020
- exercised options over 3,672 shares of Axsome Therapeutics (a derivative holding)SEC Form 45 July 2019Stock Option (Right to Buy) · traded 3 July 2019 · filed 5 July 2019
- exercised options over 39,948 shares of Axsome Therapeutics (a derivative holding)SEC Form 45 July 2019Stock Option (Right to Buy) · traded 3 July 2019 · filed 5 July 2019
- exercised options over 13,000 shares of Axsome Therapeutics (a derivative holding)SEC Form 45 July 2019Stock Option (Right to Buy) · traded 3 July 2019 · filed 5 July 2019
- exercised options over 3,672 shares of Axsome TherapeuticsSEC Form 45 July 2019Common Stock · traded 3 July 2019 · filed 5 July 2019
- exercised options over 39,948 shares of Axsome TherapeuticsSEC Form 45 July 2019Common Stock · traded 3 July 2019 · filed 5 July 2019
- exercised options over 13,000 shares of Axsome TherapeuticsSEC Form 45 July 2019Common Stock · traded 3 July 2019 · filed 5 July 2019
- was granted 13,000 shares of Axsome Therapeutics (a derivative holding)SEC Form 410 June 2019Stock Option (Right to Buy) · traded 7 June 2019 · filed 10 June 2019
- was granted 34,866 shares of Axsome Therapeutics (a derivative holding)SEC Form 421 March 2019Stock Option (Right to Buy) · traded 19 March 2019 · filed 21 March 2019
- was granted 13,000 shares of Axsome Therapeutics (a derivative holding)SEC Form 45 June 2018Stock Options (right to buy) · traded 1 June 2018 · filed 5 June 2018
- was granted 39,948 shares of Axsome Therapeutics (a derivative holding)SEC Form 45 April 2018Stock Option (Right to Buy) · traded 12 March 2018 · filed 5 April 2018
- exercised options over 7,344 shares of Axsome TherapeuticsSEC Form 430 March 2017Common Stock · traded 29 March 2017 · filed 30 March 2017
- exercised options over 35,194 shares of Axsome TherapeuticsSEC Form 430 March 2017Common Stock · traded 29 March 2017 · filed 30 March 2017
- exercised options over 7,344 shares of Axsome Therapeutics (a derivative holding)SEC Form 430 March 2017Stock Option (Right to Buy) · traded 29 March 2017 · filed 30 March 2017
- exercised options over 35,194 shares of Axsome Therapeutics (a derivative holding)SEC Form 430 March 2017Stock Option (Right to Buy) · traded 29 March 2017 · filed 30 March 2017
- was granted 35,194 shares of Axsome Therapeutics (a derivative holding)SEC Form 417 March 2017Stock Option (Right to Buy) · traded 15 March 2017 · filed 17 March 2017
- was granted 11,000 shares of Axsome Therapeutics (a derivative holding)SEC Form 417 March 2017Stock Option (Right to Buy) · traded 15 March 2017 · filed 17 March 2017
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.